Literature DB >> 18396509

Augmentation strategies in the treatment of major depressive disorder. Examining the evidence on augmentation with atypical antipsychotics.

George I Papakostas1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18396509     DOI: 10.1017/s1092852900016023

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


× No keyword cloud information.
  5 in total

1.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

2.  Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan J Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11-15       Impact factor: 5.270

3.  Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  George I Papakostas; Maurizio Fava; Lee Baer; Michaela B Swee; Adrienne Jaeger; William V Bobo; Richard C Shelton
Journal:  Am J Psychiatry       Date:  2015-06-18       Impact factor: 18.112

Review 4.  Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder.

Authors:  Ashwin A Patkar; Chi-Un Pae
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

Review 5.  Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.

Authors:  George I Papakostas; Maurizio Fava
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.